Navigation Links
Crannose(TM) Extra Strength Women's Health Formula Targets Urinary Tract Infections
Date:4/1/2008

ORLANDO, Fla., April 1, 2008 /PRNewswire/ -- Valensa International introduced Crannose(TM) Extra Strength Women's Health Formula at this year's Natural Products Expo West Conference. This patent-pending supplement, manufactured using novel CIT technology, combines the historically known benefits of cranberry with D-mannose, a naturally occurring, non-caloric, simple sugar, extracted from the Larch tree. The product is available in bulk, 2-piece capsules, as a beverage pre-mix or beverage sachet formula.

According to Dr. Rudi E. Moerck, President of Valensa, there is a viable and growing market for a natural promoter of urinary tract health that can affect the conditions that lead to urinary tract infections (UTIs). "Antibiotics are the standard drug-based treatment for UTIs, but they often eliminate a woman's 'good' vaginal bacteria in the course of treating the targeted infection. This situation often leads to painful secondary fungal infections like Candida that can themselves require drug treatment. The increased use of antibiotics generally has contributed to antimicrobial resistance, a growing public health concern," he added.

Dual action targets urinary tract health

During UTIs, E. coli bacteria gain a foothold by adhering to the bladder wall and/or urethra, causing infection. Crannose(TM) Extra Strength creates an environment in the bladder that helps prevent bacteria from gaining that foothold. Supplementation with Crannose(TM) Extra Strength helps to acidify the urine, while its anti-adhesion properties naturally prevent bacteria from attaching to the urinary tract lining. It provides an ideal competitive receptor site for the bacteria, creating a "path of least resistance" for it to be excreted quickly and harmlessly.

Crannose(TM) Extra Strength is very slowly metabolized in the body, so that when ingested, it travels directly to the bloodstream from the upper GI tract, and is filtered through the kidneys to the bladder f
'/>"/>

SOURCE Valensa International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New study: Pine bark extract reduces ADHD symptoms in children
2. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
3. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
4. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
5. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
6. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
7. Portal vein thrombosis is common in extraportal vein obstruction
8. New study: pine bark extract boosts nitric oxide production
9. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
10. Broccoli sprout-derived extract protects against ultraviolet radiation
11. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...omen who got injections report reduced pain and s...) -- The first evidence that gene therapy can ease... has been reported by American and German research...e women,s affected joints. IL-1Ra protein blocks t...
... COLUMBUS, Ga., Feb. 6 Aflac Incorporated,annou... its holdings of,perpetual debenture securities at...nal information to its web site on each,Upper Tier... and elevated a frequently asked questions (FAQ) d...
...plies tend to run dangerously short this time of y... The holiday season is long gone, and everyone has... still one gift left to give, one that,s desperate...tions. Now that the new year is under way, there,s...
... This Valentine,s Day unpro... sweeteners and berries to produce a new type of c...rties. Dieting and the benefits of berry antioxida...ng been regarded as a sweet and sinful indulgence....
...utations could increase cancer risk almost 6-fold,...thDay News) -- Scientists have identified two gene...creased risk of developing thyroid cancer. , This ...cording to the U.S. National Cancer Institute. , "...
... KePRO,s Chief Medical Offi... care and quality of life , ...ce Stollenwerk Petrulis , MD, FACP, has been appoi...and care management, will work with other leading ...
Other Medicine News:Health News:Gene Therapy May Ease Rheumatoid Arthritis 2Health News:Aflac Incorporated Provides Added Detail on Perpetual Debenture Holdings 2Health News:Needed: Blood Donations 2Health News:Needed: Blood Donations 3Health News:Losing Weight with Chocolate on Valentine's Day 2Health News:Gene Test Could Predict Thyroid Cancer Risk 2Health News:Gene Test Could Predict Thyroid Cancer Risk 3Health News:Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee 2
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers of the AcceleDent System , which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Stay Upbeat Active to Keep the Mind Young 49889 1Stay Upbeat Active to Keep the Mind Young 49889 2Stay Upbeat Active to Keep the Mind Young 49889 3WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety Efficacy and Compliance for Medicai 49887 1WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety Efficacy and Compliance for Medicai 49887 2WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety Efficacy and Compliance for Medicai 49887 3WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety Efficacy and Compliance for Medicai 49887 410th CyberKnife System Installed at an HCA Hospital 49885 110th CyberKnife System Installed at an HCA Hospital 49885 210th CyberKnife System Installed at an HCA Hospital 49885 310th CyberKnife System Installed at an HCA Hospital 49885 4
...rst study evaluating DUROS(R) continuous delivery ..., , HAYWARD, Calif., April 24 Intarcia Therapeut...t accrual to a phase 1b clinical study evaluating ...e). The study is being conducted at multiple cente... of 44 patients with type 2 diabetes for a period ...
...votal Trial Expected to Initiate in 2010 for Blina...asdaq: MITI ), a biopharmaceutical company devel...ent of cancer, inflammation and autoimmune disease...ancial analysts at The Yale Club of New York City....areas of development across Micromet,s BiTE antibo...
Other Medicine Technology:Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4
Serdarevic Suture Hook
Osher "Y" Hook
Fenzl Insertion Hook
Heath Chalazion Curette
Medicine Products: